Alps Advisors Inc

SEC CIK: 0001376113
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

NGM holding history

NGM Biopharmaceuticals Inc in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NGM overview All 13F holders of NGM Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of NGM by Alps Advisors Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−54,054−100.0%	Sold out	Holders
Q1 2023	54,054	$220.5K	<0.1%	−1,466−2.6%	Reduced	Holders
Q4 2022	55,520	$278.7K	<0.1%	+55,520	New	Holders